CRBP

Corbus Pharmaceuticals Holdings, Inc.

Contracts

Total Value

Stock Metrics

18.0%

Short % Float

9.4d to cover · Moderate squeeze

73.6%

Inst % Float

10 holders · 2026-06-30

Cormorant Asset Ma

Top Holder

12.1% of float

12.7M sh

Public Float

59/100

Dilution Score

High

26 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

59/100

HIGH

Inst: 73.64% · Top: Cormorant Asset Management, LP

Biotech Analytics

Oncology

31.25

Dilution Risk: HIGHSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk59

Clinical Trials38

Short Interest50